On 15 April 2014
AstraZeneca Pharma India at the board meeting held on 15 April 2014, has deferred the proposal for delisting of its shares proposed by the promoters of the company.The decision has been deferred due to delay in response from the discussions held by the company with ICICI Securities Limited, the Manager and Walker Chandoik & Co LLP, the Valuer.
Powered by Capital Market - Live News
